You searched for "infections"
First systematic review of COVID-19 colonisation of ocular tissues and secretions
The authors present the first systematic review summarising all the data regarding SARS-CoV-2 colonisation of ocular and periocular tissues and secretions. They reviewed all publications between December 2019 to April 2020 in the Cochrane Library, Medline, World of Science and...
Displacement of submacular haemorrhage – comparative study pneumatic displacement versus subretinal cocktail injection
The authors report a multicentre retrospective interventional case series study comparing the outcome of submacular haemorrhage (SMH) using pneumatic displacement with intravitreal expansile gas versus treatment with pars plana vitrectomy (PPV) versus subretinal injection of tissue plasminogen activator (tPA), anti-vascular...
Review of chalazion treatment
Even though chalazion is a common eyelid lesion, there is lack of consensus on a treatment algorithm. Conservative management includes lid hygiene and warm compresses and, in some cases, steroid ointments for two to three weeks. More invasive options for...Moorfields Education: Botulinum toxin: Is it injector error, side effects or complications
This is an advanced course intended for practitioners who injection the adnexa of the eyes and face including doctors, neurologists, physiotherapists, dystonia and aesthetic nurse/practitioners. It will provide the chance to improve your clinical practice and treatment, management and administration of botulinum toxin for blepharospasm, hemifacial spasm, bells palsy, gustatory lacrimation and entropion.WATCH: Beyond 2020 with the Andean Medical Mission
This Andean Medical Mission series is called Beyond 2020, and focuses on the many aspects of creating services which will ultimately impact on eliminating avoidable blindness in countries with developing eyecare services.WATCH: Beyond 2020 with the Andean Medical Mission
This Andean Medical Mission series is called Beyond 2020, and focuses on the many aspects of creating services which will ultimately impact on eliminating avoidable blindness in countries with developing eyecare services.Regulatory drug evaluations and expedited review initiatives: EU and US perspectives
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...
Vision loss during Eylea treatment for AMD
This report investigated patients who lost more than two lines of vision despite periodic injections of aflibercept and explored the factors associated with vision loss. One hundred and ninety-six eyes were included in this study over a two year period....
The effects of anti-VEGF therapy for NvAMD on retinal vasculature
This retrospective consecutive case series examined 54 eyes of 54 treatment-naïve neovascular age-related macular degeneration (N-AMD) patients. Thirty-three eyes received intravitreal aflibercept injections, and 21 eyes received intravitreal ranibizumab injections with unaffected fellow eyes (54 eyes) as controls. All image...
Progression of macular atrophy on long-term anti-VEGF therapy for AMD
This retrospective study evaluated the progression of macular atrophy in 53 eyes of 53 patients receiving AntiVEGF Therapy for age-related macular degeneration (nAMD), for at least six years. None of the patients had any macular atrophy (MA) at presentation. MA...
